These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25947160)

  • 21. Knowledge management as a mediator for the efficacy of transformational leadership and quality management initiatives in U.S. health care.
    Gowen CR; Henagan SC; McFadden KL
    Health Care Manage Rev; 2009; 34(2):129-40. PubMed ID: 19322044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-Performance Work Practices and Interpersonal Relationships:
    Salin D; Baillien E; Notelaers G
    Front Psychol; 2022; 13():854118. PubMed ID: 35572242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pessimistic response to FDA leadership change.
    Kling J
    Nat Biotechnol; 2005 Nov; 23(11):1325. PubMed ID: 16273044
    [No Abstract]   [Full Text] [Related]  

  • 24. Australian pharmaceutical policy: price control, equity, and drug innovation in Australia.
    Doran E; Alexander Henry D
    J Public Health Policy; 2008 Apr; 29(1):106-20. PubMed ID: 18368023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management consulting for scientists.
    Kulkarni S
    Nat Biotechnol; 2007 Dec; 25(12):1489-90. PubMed ID: 18066046
    [No Abstract]   [Full Text] [Related]  

  • 26. Rapid adoption network approach yields successful collaboration.
    Healthcare Benchmarks Qual Improv; 2011 Mar; 18(3):25-6, 29-30. PubMed ID: 21449515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Living excellence: life after Magnet designation.
    Malloch K
    Nurs Adm Q; 2009; 33(2):93-8. PubMed ID: 19305304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E-health & pharmaceuticals.
    Appleby C
    Health Forum J; 2001; 44(1):17-21. PubMed ID: 11225552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A framework for the management of intellectual capital in the health care industry.
    Grantham CE; Nichols LD; Schonberner M
    J Health Care Finance; 1997; 23(3):1-19. PubMed ID: 9089446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Back to the future: driving innovation in drug development.
    Wagner JA
    Clin Pharmacol Ther; 2008 Feb; 83(2):199-202. PubMed ID: 18202681
    [No Abstract]   [Full Text] [Related]  

  • 31. Innovation in biotechnology: current and future states.
    Woollett GR
    Clin Pharmacol Ther; 2012 Jan; 91(1):17-20. PubMed ID: 22179626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biotechs hold their own in shifting industry.
    Mitchell P
    Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238
    [No Abstract]   [Full Text] [Related]  

  • 33. Opinion: the pharmaceutical industry welcomes governor-elect Jim McGreevey.
    Perkins R
    N J Med; 2001 Dec; 98(12):64, 63. PubMed ID: 11778297
    [No Abstract]   [Full Text] [Related]  

  • 34. Roche: blending independent and commercial research.
    Woods D
    Can Med Assoc J; 1983 Oct; 129(7):743-52. PubMed ID: 6351991
    [No Abstract]   [Full Text] [Related]  

  • 35. Speech-language pathologists and the Common Core Standards initiative: an opportunity for leadership and organizational change.
    Dunkle J; Flynn P
    Semin Speech Lang; 2012 May; 33(2):102-10. PubMed ID: 22538707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Father figures. HMO creator sees need for new model. Interview by Laura B. Benko.
    Ellwood P
    Mod Healthc; 2006 Jun; 36(25):6, 24. PubMed ID: 16827462
    [No Abstract]   [Full Text] [Related]  

  • 37. Models for open innovation in the pharmaceutical industry.
    Schuhmacher A; Germann PG; Trill H; Gassmann O
    Drug Discov Today; 2013 Dec; 18(23-24):1133-7. PubMed ID: 23892183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Keynote review: Is declining innovation in the pharmaceutical industry a myth?
    Schmid EF; Smith DA
    Drug Discov Today; 2005 Aug; 10(15):1031-9. PubMed ID: 16055019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curbing the cardiovascular disease epidemic: aligning industry, government, payers, and academics.
    Califf RM; Harrington RA; Madre LK; Peterson ED; Roth D; Schulman KA
    Health Aff (Millwood); 2007; 26(1):62-74. PubMed ID: 17211015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redistribution of risk throughout the pharmaceutical industry.
    Scheur BS
    Med Interface; 1994 Oct; 7(10):77-80. PubMed ID: 10137569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.